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Potential of Equine Embryos 
 
Richard O. Gearhart 
 
 
 This study investigated the development potential of equine embryos 
in vitro after biopsy and vitrification.  Twenty embryos were obtained from 
Quarter Horse, Thoroughbred, and mix-breed light mares between three and 
ten years old. The twenty embryos were divided into a biopsy (n=10) and 
control group (n=10).  The biopsy group underwent microaspiration biopsy 
using a micromanipulator to obtain a small tissue sample from the embryo.  
Both groups were then vitrified using a commercially available technique 
originally described by Carnevale (2006) at Colorado State University. 
 All 20 embryos were cultured in DMEM/Hams F-12 medium under 
oil at 37°C in 5% CO2 in air (Hinrichs et al., 1990).  Embryos were 
monitored for expansion and hatching.  Embryo development was 
statistically different between the two groups (p<0.05).  The biopsy 
procedure did result in a much lower development potential in the biopsy 
group as compared to the control group (20% vs. 80%).  However, embryos 
in the biopsy group did show expansion and hatching therefore the combined 
procedure did not preclude development potential in vitro.  Based on these 
 v 
findings, more research needs to be done to increase the success of the 
combined procedure and the ultimate viability of the embryos needs to be 
confirmed with the establishment of successful pregnancies. 
Key Words:  Vitrification, embryo biopsy, microaspiration, 
micromanipulation, and embryo culture. 
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 The development and use of embryo transfer in the horse has 
progressed steadily and foals resulting from embryo transfer are now 
permitted in most breed registries (Squires et al., 2003).  However embryo 
technologies in the horse have lagged behind that of other livestock species.  
Several unique biological features as well as technical problems have limited 
embryo technology advancement in the horse as compared to that of the 
cattle industry (Squires, 1999).   The lack of an effective superovulation 
technique in the horse combined with a reluctance of some breed registries 
to embrace newer embryo technologies has limited the development and 
commercialization of techniques now considered to be commonplace in the 
cattle industry.  In vitro fertilization, intracytoplasmic sperm injection, 
oocyte freezing, embryo biopsy, and embryo cryopreservation can still be 
considered developing technologies in the horse (Squires et al., 2003).   
 It is likely that advancements will continue to be made in the future as 
breed registry rules change and newer techniques are developed to allow 
superovulation in the mare.  It also seems sensible that the most economical 
way of moving genetic material throughout the world is in a cryopreserved 
state (Squires et al., 2003).  The use of pre-implantation genetic diagnosis 
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could be used to enhance the value of embryo cryopreservation and lead to 
more successful commercialization of embryo technologies.  
Preimplantation genetic testing would allow for the culling of embryos with 
genetic mutations and the marketing of embryos known to result in foals of a 
specific color or gender. 
Purpose 
 The unique characteristics of equine embryo development make 
equine embryo cryopreservation a labor intensive and expensive process.  
The equine embryo forms a thin glycoprotein capsule as it expands into a 
blastocyst.  The capsule is resistant to cryoprotectants, therefore successful 
equine embryo cryopreservation must be carried out prior to capsule 
formation. This presents a problem unique to the horse as the equine embryo 
normally passes from the oviduct into the uterus 5.5 days post ovulation and 
the glycoprotein capsule begins to form 6.5 days post ovulation (Freeman et 
al., 1991). The short duration between the arrival of the embryo in the uterus 
and capsule formation presents a very narrow window of opportunity during 
which the embryo can be collected and frozen.  As embryos are collected 
using non-surgical uterine lavage, mares must be monitored closely by 
ultrasound to determine the time of ovulation.  Even with close monitoring, 
the expected number of embryos recovered is fewer than 1 per lavage.  
 4 
Because of the expense and low number of embryos recovered, equine 
embryo cryopreservation is not economically viable and research for better 
techniques has not resulted in success similar to other livestock species, 
although an effective and commercially available vitrification process that 
allows for quick cryopreservation of equine embryos without specialized 
equipment has been developed (Carnevale, 2006).  
 Pre-implantation genetic diagnosis could add value to equine embryo 
cryopreservation.  If equine embryos could be genetically tested prior to 
cryopreservation, it could confirm the resulting foal would be genetically 
normal and even determine the potential foal’s gender and color.  Genetic 
tests are currently available to test for several inherited diseases commonly 
found in various horse breeds including Hyperkalemic Periodic Paralysis 
(HYPP) Disease, Glycogen Branching Enzyme Deficiency (GBED), 
Junctional Epidermolysis Bullosa (JEB), and HERDA - Hereditary equine 
regional dermal asthenia. 
 The purpose of this study is to determine if embryo biopsy performed 
prior to cryopreservation will affect embryo viability in vitro. 
Research Goals 
 The main goal of this study is to investigate the effect of embryo 
biopsy and subsequent cryopreservation (vitrification) on the development 
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potential of equine embryos.  The working hypothesis tested in the study is 
that combining vitrification and biopsy of equine embryos does not alter the 
development potential of equine embryos in vitro. 
 The specific objectives are: 
 (1) To determine if embryo biopsy affects in vitro development of the 
equine embryo. 
 (2) To determine if embryo biopsy and vitrification treatment 
combined inhibits in vitro development of equine embryos more than 
embryos treated by vitrification alone (no biopsy).   
 Demonstrating the potential for development in vitro of equine 
embryos after combining the two techniques would help establish the 
potential for further research in vivo. 
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Embryo Technologies in the Horse 
 Although artificial insemination was probably used on the horse 
before any other large animal species, it was the last to undergo embryo 
recovery and transfer (Allen, 2005). The techniques of embryo collection 
and transfer in horses were developed in the 1970’s (Squires et al., 2003).  
The lag in further development of embryo technologies in the horse 
compared to other livestock species is often blamed on the initial 
unwillingness of breed registries to accept foals produced by embryo 
transfer and the lack of an effective superovulation protocol for mares.  In 
addition, the first attempts at non-surgical embryo transfer had relatively low 
success (Allen & Rowson, 1972; Squires et al., 1985).  It appears as horse 
producers discovered the potential commercial benefits of embryo 
technologies, research increased.  Great progress in the non-surgical 
technique was made in the 1990s especially in Argentina where high value 
polo ponies are produced (Pashen et al., 1993; Riera & McDonough, 1993).  
Progress began to increase in America when the restrictions limiting the 
number of offspring that could be registered as a result of embryo transfer 
was lifted from the American Quarter Horse Registry (Hudson & McCue, 
2004).  Preimplantation genetic testing has the potential to increase the 
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commercial appeal of embryo technologies even more and thus encourage 
research.  
Embryo Collection 
 The recovery of embryos from a donor mare is a straightforward 
process.  The relatively straight and easily distensible cervix of a mare make 
it a simple process to pass a two-way catheter into the body of the uterus 
(Allen, 2005).  An inflatable cuff on the end of the catheter allows the 
internal opening of the cervix to be sealed.  An embryo-flushing medium is 
then used to distend the uterus and dislodge the embryo.  The medium is 
recovered by gravity flow through an in-line embryo filter cup.  The contents 
of the filter cup is carefully searched under a microscope and the embryo 
recovered.  The direct transfer to a recipient mare is also a straightforward 
procedure and with proper embryo handling can result in acceptable 
pregnancy rates of 75%-85% (Pashen et al. 1993; Meadows 
et al. 2000; Jasko 2002).  However, the transfer of frozen equine embryos 
presents some additional challenges. 
 Equine embryos take an unusually long time to pass from the oviduct 
into the uterus (Allen, 2005).  Because equine embryos remain in the oviduct 
for 144 to 168 hours, most are collected 7 to 8 days post ovulation (Battut et 
al., 2000).  Multiple studies have shown that embryos greater than 300μm 
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are unsuitable for cryopreservation (Squires et al., 2003).  Blastocyst 
formation and expansion begins 6-7 days post ovulation (Grondahl & Hytell, 
1996).  This creates a problem for collecting morula or early blastocyst 
(<300μm) stages needed for successful cryopreservation. There is a very 
narrow window of opportunity when the embryo is in the uterus, but is still 
small enough for cryopreservation. Carnevale (2006) described a method to 
increase the number of morulae and early blastocysts recovered smaller than 
300μm by timing the flushes from ovulation induction. Ovulation occurs 
approximately 36 hours after the administration of human chorionic 
gonadotropin (hCG) and approximately 40 hours after administration of a 
gonadotropin-releasing hormone (GnRH) analogue (deslorelin).  Carnevale 
(2006) demonstrated that embryo flushes can be carried out exactly eight 
days from administration of an ovulation-inducing hormone to collect 
embryos small enough for vitrification (<300?m).  But even with the 
improved methods of embryo collection, the mean embryo recovery per 
cycle is approximately 50% (Squires et al., 2003). 
Superovulation 
 The failure of the mare and other equids to undergo genuine 
superovulation in response to treatment with exogenous gonadotrophic 
hormones has been a major limiting factor to the commercial development 
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of equine embryo transfer from the outset (Allen, 2005).  There are 
numerous accounts of as many as 20-30 viable embryos from cattle, sheep, 
and pigs from a single uterine flush when superovulation was induced.  
Despite a commercial, partially purified extract of equine FSH being 
available, the effectiveness remains disappointingly low.  Alvarenga et al. 
(2000) reported an improved embryo recovery of 3.5 embryos per cycle in 
mares treated twice daily for 6-8 days with eFSH.  However commercial 
embryo recovery remains at a mean of just 1.8 per flush for treated mares 
compared to a recovery of .85 embryos per cycle from non-treated donor 
mares (Allen, 2005).  While research is still being conducted on mare 
ovarian stimulation, there appears to be a basic physiologic challenge to 
superovulation.  Allen (2005) notes that equine follicles can only ovulate 
and release their oocytes through the ovulation fossa because of the very 
tough and fibrous tunica albuginea covering the external surface of the 
ovary.  Even with increased follicle development, the number of embryos 
recovered is low.   According to Allen this implies that the follicles compete 
with one another in their attempt to track through the ovary toward the 
ovulation fossa.   While it is possible to slightly increase the number of 
ovulations per cycle, it still doesn’t approach the 20 embryos per cycle 
demonstrated in other livestock species. 
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 With the low response to treatment with expensive hormones, 
superovulation still is not commercially viable in the equine.  Most embryo 
recoveries in equids are performed on spontaneously ovulating mares 
(Squires et al., 2003).  The recovered embryos are then directly transferred 
to recipient mares.  In other livestock species, the number of recovered 
embryos often exceeds the number of available recipients resulting in excess 
embryos.  With a lack of extra embryos in the equine, research on 
cryopreservation and other embryo technologies has continued to be slow to 
develop.  Without the ability to produce large numbers of embryos through 
superovulation, opportunities for research have also been limited. 
Embryo Cryopreservation 
 Techniques for the transfer of frozen equine embryos have lagged 
well behind that of bovine embyos mainly because of biological reasons 
(Squires et al., 2003).  Because of the lack of an effective superovulation 
protocol in horses, typically only a single embryo is recovered and 
immediately transferred to a recipient mare.  However in bovine embryo 
transfer, donor cattle often produce in excess of 20 embryos (Allen, 2005).  
The number of embryos collected often exceeds the number of recipients 
available.  The lack of recipients created a need for embryo cryopreservation 
research (Galli et al., 2003).  According to Galli et al. (2003), large numbers 
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of bovine embryos can also be produced using ovaries of slaughtered 
donors.  The ovaries are often pooled and processed as a batch.  This 
simplifies the process and consequently embryos are produced at low cost.  
This gives researchers an abundant source of embryos.   
 Equine embryos also form a unique, thin glycoprotein capsule which 
resists the penetration of cryoprotectants and makes the freezing of 
blastocysts and expanded blastocysts very difficult (Legrand et al. 2000).  
Squires et al., (2003) reported that several investigators have demonstrated 
embryos <300μm in size (before the capsule forms) survive freezing and 
thawing, whereas larger embryos have much lower survival rates.   
 A significant advance occurred in embryo freezing with the 
application of vitrification (Allen, 2005).  Vitrification is a process that uses 
high concentrations of permeating cryoprotectants to flash freeze the 
embryo.  Damaging ice crystals do not form and instead a glass-like state is 
achieved (Carnevale, 2006).  Carnevale (2006) reported pregnancy rates of 
60-75% when vitrifying embryos <300 μm diameter.  Unlike conventional 
embryo freezing, vitrification is a quick procedure that requires no special 
equipment and can even be carried out in field conditions.  Vitrified embryos 
can be rapidly warmed within a straw and directly transferred into the uterus 
of a donor mare (Carnevale, 2006).  
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Embryo Culture 
 Hinrichs et al. (1990) were the first to describe equine embryo 
development in long-term culture (10-20 days).  The investigators recovered 
morulae stage embryos via non-surgical lavage and placed them in culture 
media.  The embryos were maintained at 37°C in a 5% CO2 atmosphere.  
The embryos expanded by the third day of culture and later hatched from 
their zona, rather than the zona thinning and flaking off as occurs in vivo 
(Hinrichs et al., 1990).  According to Hinrichs et al. (1990), the results of 
their study indicate that horse embryos can consistently maintain growth and 
expansion for 10 days in vitro.  
Embryo Biopsy 
 The use of embryo biopsy for pre-implantation genetic testing has 
been around for quite some time in horses and other livestock species.  
Huhtinen et al. (1997) were able to establish successful pregnancies that 
resulted in live foals in 1994.  The embryos were biopsied using a 
microblade procedure removing 10-30 blastomeres from day 6 embryos 
(Huhtinen et al., 1997).  DNA from the biopsied cells was amplified using 
polymerase chain reaction (PCR) to determine the resulting foals gender.  
The pregnancy rate as reported by Huhtinen et al. (1997) was significantly 
lower in the biopsy group (3/14) vs. the control group (6/8), but the authors 
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pointed out that better biopsy techniques and earlier embryo recovery 
(before the glycoprotein capsule formed) could potentially improve 
pregnancy rates.  The authors also noted that improved pregnancy results 
along with more identified genes associated with particular diseases or 
inherited characteristics could be used for preimplantation genetic 
diagnostics (Huhtinen et al., 1997).  A biopsy technique that utilized a 
micro-needle to remove a smaller portion of the embryo was described by 
Agca et al. in 1995.  Embryos were held in place by suction applied to a 
glass holding pipette.  The pipette was controlled by a joystick-type 
micromanipulator.  An aspiration pipette was then inserted through the zona 
pellucida and 2-3 blastomeres were removed by suction.  The cells were left 
in the media drop and later recovered for genetic testing (Agca et al., 1995). 
PCR 
 Polymerase chain reaction (PCR) is a tool used to amplify specific 
DNA sequences from minute quantities of cellular material.  Using PCR, 
genes have been identified from embryonic material of many species 
(Huhtninen, et al. 1997).  Successful DNA amplification has been carried 
out on bovine and murine blastocysts (King & Wall, 1988), murine demi-
morulae (Ninomiya et al., 1990), bovine demi-blastocysts (Peura et al., 
1991), ovine 3-cell biopsies (Bredbacka & Peippo, 1992), equine demi-
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blastocysts (Huhtinen et al., 1997), and single blastomeres from human 
(Verlinsky et al., 1991) and bovine (Machaty et al., 1993) embryos. 
Genetic Testing 
 The American Association of Equine Practitioners (AAEP) supports 
the use of genetic testing by veterinarians or breed associations to identify 
genetic mutations in animals so that owners can make informed decisions 
about breeding, purchase and specific treatments (American Association of 
Equine Practitioners, 2009).  According to the association, there are genetic 
tests for 9 diseases. 
Autosomal Dominant Diseases 
1. Hyperkalemic Periodic Paralysis (HYPP) in the Quarter Horse 
2. Type 1 Polysaccharide Storage Myopathy (PSSM) in numerous 
breeds 
3. Malignant Hyperthermia in Quarter Horse related breeds 
Autosomal Recessive Diseases 
4. Overo Lethal White Syndrome in the Paint Horse 
5. Combined immunodeficiency in Arabian Horses 
6. Glycogen Branching Enzyme Deficiency (GBED) in Quarter Horse 
related breeds 
7. Junctional Epidermolysis Bullosa (JEB) in Belgians 
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8. JEB in Saddlebred horses 
9. Hereditary Equine Regional dermal Asthemia (HERDA) in Quarter 
Horse related breeds 
 AAEP also notes that there are numerous other conditions strongly 
suspected to be due to mutations in genes of major effect, but genetic tests 
are not yet available.  Genetic testing for all of these diseases could also be 
presumably carried out on single blastomeres using the PCR amplification 
technique.  In addition, there are tests for coat color genetics and gender. 








 Embryos were obtained between February and September during the 
regular breeding season from Quarter Horse, Thoroughbred, and mix-breed 
light mares between three and ten years old.  Mares and stallions underwent 
reproductive evaluation to ensure fertility before being included in the study.  
Follicular growth was monitored daily via transrectal palpation and 
ultrasonography.  Mares with follicles >35 mm were bred via artificial 
insemination with fresh semen collected from Quarter Horse and Welsh 
stallions.  After insemination, mares were injected with hCG (2500 IU 
administered IV) or deslorelin (1.5mg IM).  Mares were monitored via 
transrectal ultrasonography at 24 and 48 hours post insemination to confirm 
ovulation. 
 Mares were re-checked via ultrasound 5 days post ovulation.  If the 
mares appeared free of fluid and uterine edema, they were flushed via non-
surgical, trans-cervical uterine lavage 6.0-6.5 days post-ovulation.  Sedation 
was provided prior to embryo recovery using 0.5mg/kg zylazine 
administered intravenously.  An embryo catheter with a 60-75cc balloon was 
attached to Y tubing and inserted transcervically into the uterine body of the 
mare.  The balloon was inflated to capacity with flush media to seal the 
cervix and mild pressure was applied in a caudal direction to seat the 
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catheter against the internal cervical os.  Four 1L increments of flush media 
(BioLife Advantage Complete Flush Media, Agtech, Inc., Manhattan, KS) 
were used to flush the uterus.  Fluid was collected as it exited the uterus in a 
cup with a 75-micron filter.  After the flush was complete, 20 ml of flush 
media was allowed to remain in the cup.  The cup was then rinsed with 
additional flush media into a search dish.    
Embryo Identification 
 The dish was examined under a microscope at 10x power.  Embryos 
were identified by developmental stage and grade (Table 1).  Once 
identified, embryos were washed four times through embryo holding media 
(Vigro Holding and Transfer Medium, Bioniche Animal Health USA Inc., 
Pullman, WA). 
 The embryos were temporarily placed in holding media in a 2ml 
cryotube and held at room temperature for transport to the laboratory.  Total 
time from identification to treatment was less than 1 hour. 
Biopsy and Vitrification 
 Embryos underwent micromanipulation and biopsy prior to being 
cryopreserved.  Embryos were placed in biopsy media (Embryo Biopsy 
Medium, Irvine Scientific, Santa Ana, CA) under oil and viewed under a 
microscope at 20x power.  A small amount of tissue was removed from each 
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embryo using a microaspiration technique.  Embryos were held in position 
by gentle suction from a holding pipette using a micromanipulator.  A small 
hole was mechanically made in the zona pellucida using a second 
micromanipulator and a microneedle.  A small amount of tissue was  gently 
aspirated and placed in the media near the embryo for later removal (Fig. 1).  
Once the biopsy procedure was complete, the tissue samples were frozen in 
1ml cryotrubes and stored at -20°C. 
 The biopsied embryos and control embryos (embryos not undergoing 
biopsy) were then vitrified according to the protocol described by Carnevale 
and co-workers (2006) at Colorado State University.  During the vitrification 
procedure, embryos are sequentially moved through three vitrification 
solutions containing various combinations of glycerol and ethylene glycol as 
cryoprotectants. To facilitate movement of the embryos from one 
vitrification solution to the next and the rapid loading of the freezing straw, 
the vitrification and diluent solutions can be set up on the lid of a Petri dish 
(Fig. 2).  A timer is necessary to ensure the proper exposure time to each of 
the three vitrification solutions.  Embryos are removed from the biopsy 
media and placed into vitrification solution 1 (glycerol [1.4 M]).  Movement 
of the embryo is made with a small volume of media (<1?L) to ensure the 
embryo is exposed to the proper concentration of cryoprotectants.  The 
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embryo remains in vitrification solution 1 for 5 minutes and then promptly 
moved to vitrification solution 2 (glycerol [1.4 M] plus ethylene glycol [3.6 
M]) for 5 minutes.  The embryo is then placed in vitrification solution 3 
(glycerol [3.4 M] plus ethylene glycol [4.6 M]).  The embryo is exposed to 
vitrification solution 3 for less than 1 minute before being placed in liquid 
nitrogen vapor.  To facilitate rapid loading of the freezing straw, the embryo 
is placed in a 30?L drop of vitrification solution 3, the exact amount to be 
drawn up into the straw (Carnevale, 2006). 
  A 0.25-ml semen straw (nonirradiated, polyvinyl chloride) is loaded 
with the embryo in the final vitrification solution between two sections of 90 
-?L of diluent solution (galactose; 0.5M) to allow dilution of cryoprotectants 
in the straw after warming (Fig. 2). The straw is loaded for vitrification with 
90 ?L galactose, air (5 ?L), the embryo in vitrification solution 3 (30 ?L), 
air (5 ?L), and 90 ?L galactose.  The straw is then sealed with a heat sealer 
and placed in liquid nitrogen vapor (Carnevale, 2006).  No special 
equipment is required for vitrification; the straw containing the embryo is 
exposed to vapor for 1 minute before plunging it into liquid nitrogen. 
Embryos were stored in liquid nitrogen until thawing and culture. 
Embryo Thawing 
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 Warming of the straw requires no special equipment.  Biopsied and 
control embryos were warmed within the straw.  The straw was held in the 
air for 10 seconds and then plunged in water (37° C) for 10 seconds.  The 
straw was then shaken to mix the contents (Carnevale, 2006).  The contents 
of the straw including the embryo were expelled into holding media (BioLife 
Holding and Transfer Medium, Agtech, Inc., Manhattan, KS).  
Embryo Culture 
 The embryos were identified and then transferred to a 200-μl droplet 
of  culture media (HyClone HyQ DMEM/Ham’s F-12 medium 1:1,  Fisher 
Scientific, Pittsburgh, PA) supplemented with 10% fetal calf serum and 100 
mcg penicillin and 100 mcg streptomycin per ml, in a 35 mm petri dish 
under a film of filtered paraffin oil.  The culture technique used in this study 
was described by Hinrichs et. al (1990). Embryos were incubated at 
37°C in a humidified atmosphere of 5% CO2 in air. The medium was not 
changed during the culture period. Using a dissection microscope at 10-50x 
power, embryos were evaluated for normal development daily for 5 – 10 
days of culture (until the embryos stopped expanding or degenerated). 
Embryo morphology was recorded.  Embryo viability could not be assessed 
as no pregnancies were established, however development potential was 
defined as blastocele expansion with thinning of the zona pellucida (Fig. 3).  
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According to Hinrichs (personal communication 2006) evidence of 
expansion (increase in diameter) especially with hatching from the zona 
should be sufficient to prove that the embryos survive vitrification and thus 
have development potential. 
Statistical Analysis 
 The development potential of the study group (biopsy combined with 
vitrification) was compared to the development potential of the control 
group (vitrification only) using a chi-square goodness of fit test.  
 The statistical model used was: 
?2 = ? [ (Oi - Ei)2 / Ei ] 
where Oi is the observed frequency count for the ith level of the categorical 
variable, and Ei is the expected frequency count for the ith level of the 
categorical variable.  For this study, the significance level is 0.05. 
 Carnevale et al. (2004) reported that 75% of vitrified embryos 
<300?m resulted in established pregnancies.  Therefore, more than 75% of 
the vitrified embryos in this study should show development potential.  
Hypothesis: 
 H0: The development potential of the vitrification only group and the 
development potential of the vitrification and biopsy group is at least 
80%.  
 23 
Ha: The development potential of the vitrification and biopsy group is 









 Embryos (<300μm) were recovered from 20 of 43 flushes (47%) 
including one set of multiple embryos. All embryos were classed 
morphologically as excellent (15/20) or good (5/20) (grade 1 or 2) (Table 1; 
Fig. 3).  The embryos were sequentially assigned to either the biopsy or 
control group.  
Embryo Development 
 Embryos were monitored daily for development potential; defined as 
expansion of the blastocele, thinning of the zona pellucide and in some cases 
hatching from the zona pellucida (personal communication Hinrichs, 2006).  
Although equine embryos do not hatch from the zona like other species in 
vivo, the embryos do hatch when cultured in vitro (Hinrichs et al., 1990).   
 The embryos that did show development potential had developed a 
well defined blastocele by day 3 in culture and those that hatched had either 
partially or completely broken free of the zona pellucida by day 5 in culture.  
None of the embryos showed any further development after 5 days in 
culture.  Figure 4 shows an example of the incomplete hatching of an 
embryo after vitrification and culture in vitro.  Figure 5 shows the complete 
hatching of the embryo.  Once free of the zona pellucida, the blastocyst 
expanded quite rapidly until it degenerated on day 5 in culture.  While 
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hatching was common, there were examples of embryos that showed 
noticeable expansion and thinning of the zona pellucida, but without 
hatching (Fig. 6).   
 The embryos with no development potential showed no signs of 
expansion or zona pellucida thinning during culture.  Figure 7 is an example 
of an embryo that did not increase in diameter and showed more 
degeneration of the blastomeres while in culture. 
 The embryos that underwent the combined vitrification and biopsy 
treatment were much less likely to show expansion and hatching, but those 
that did typically showed hatching through the zona tear created during the 
biopsy process.  Figure 8 is a biopsy embryo that hatched through the zona 
tear.  Two of the embryos in the combined treatment were not intact after 
thawing.  Neither embryo showed any kind of subsequent development 
while in culture.  Figure 9 is an example of an embryo without a defined 
zona pellucida after thawing.  
 None of the embryos in this study was transferred to a recipient and 
thus no pregnancies were established.   
Statistical Findings 
 There was a statistically significant difference (P<0.05) between the 
development potential of the biopsy group (2/10 embryos) compared to the 
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control group (8/10 embryos) (Table 2).  While the development of the 







  Equine embryo transfer was developed in the 1970s (Squires et 
al., 2003).  Since then, researchers have been able to establish successful 
pregnancies after biopsy (Huhtinen et al., 1997), culture equine embryos 
before transfer (Weimer et al., 1989), and develop a commercially available 
vitrification method (Carnevale, 2006).  What has not been accomplished is 
combining biopsy with vitrification.  The combined procedure is important 
because any genetic testing of the embryo should be carried out before 
transfer to a recipient.   
 This study looked at embryo development in vitro after biopsy and 
vitrification as a combined procedure.  Because the embryos were not 
transferred to a recipient mare and no pregnancies were established, it did 
not determine the ultimate viability of the embryos after the combined 
procedures.  Instead this study determined development potential in vitro.  
Culturing the embryos in vitro eliminates variables with the embryo transfer 
process itself.  It is important to establish whether embryos can survive the 
combined procedure before attempting to establish pregnancies.  Failure to 
establish successful pregnancies could be the result of the transfer process 
itself, rather than the biopsy/vitrification procedures.  Because Hinrichs and 
co-workers (1990) showed that equine embryos do develop in vitro, this 
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study was able to determine whether the combined procedure affected 
embryo survivability in vitro.  
 Although growth and hatching rates were much lower in comparison 
to the control group, the results do show that equine embryos can grow in 
vitro after undergoing biopsy and vitrification together thus it does not 
preclude the potential to establish successful pregnancies after the combined 
procedures.  It does however point to the need for further research to refine 
the combined procedure. 
 Because both vitrification and biopsy are established procedures 
separately, the lower success rates achieved in the treatment group can be 
attributed to the combination of the two.  The biopsy procedure requires 
creating a small tear in the zona pellucida.  The resulting tear creates an 
opening that may affect how cryoprotectants interact with the embryo.  
Changes to the vitrification procedure may be needed.  Different vitrification 
solution concentrations or a change in the exposure times may lead to 
greater success in the future.   
 The biopsy procedure may be damaging the embryo.  The two 
embryos that  showed expansion and hatching after the combined procedures 
were the last two to undergo micromanipulation.  Technician experience has 
been shown to affect pregnancy rates after non-surgical embryo transfer in 
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the horse (Iuliano et al., 1985).  Technician experience with the 
micromanipulation procedure could have affected success in this study as 
well.  
 Embryos had to be transported from the collection location to the lab.  
Carnevale (2006) recommends vitrification procedures be carried out as 
quickly as possible.  The transport time combined with the time required for 
the biopsy procedure may have affected embryo survivability.  Reducing the 
time between collection and vitrification enhance development potential. 
 Research in equine intracytoplasmic sperm injection (ICSI) has shown 
that the use of a piezo drill improves cleavage rates (Hinrichs, 2005).  The 
device causes minute vibrations in the injection pipette facilitating passage 
through the zona pellucida (Hinrichs, 2005).  The same technology could 
improve success rates with the microaspiration technique.  The technique 
used in this study requires pressure on the embryo to tear a small  opening in 
the zona pellucida.  The piezo drill makes smaller opening while exposing 
the embryo to less pressure (Hinrichs, 2005).   
 Due to budget limitations and limited facilities, this study included a 
small number of equine embryos.  A larger sample size may have provided a 




 Because this study did not preclude in vitro development of equine 
embryos after biopsy and vitrification, it shows promise for the eventual 
development of a preimplantation genetic diagnosis technique for horses.  
The ability to ensure that embryos are free from known genetic mutations 
would increase the value of embryo transfer and embryo cryopreservation to 
breeders.  Predetermining the gender and color of potential offspring could 
also make the embryos more valuable. 
 However, to take advantage of the genetic testing available, it would 
need to be carried out prior to pregnancies being established.  The ability to 
biopsy and genetically test the embryo is not practical unless the embryo can 
be stored while the testing is conducted.  This study lays the groundwork for 
the ability to store embryos that have undergone biopsy.  While Hinrichs and 
co-workers are carrying out a similar study at Texas A & M University, no 
known published research exists on combining vitrification and biopsy in the 
equine embryo.  
 Embryo technologies in the horse lag behind that of other livestock 
(Allen, 2005).  Much of this can be blamed on the lack of available equine 
embryos for research.  The lack of an effective superovulation protocol 
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means that there are very few extra embryos available.  Typically a single 
embryo is collected from a donor mare and immediately transferred to a 
recipient.  Adding value to the embryo transfer procedure could lead to 
additional research.  The ability to eliminate known genetic mutations by 
culling embryos before transfer would add value for breeders. Embryos with 
genetic mutations could be eliminated from storage before being transferred 
to a recipient.  Additionally, the ability to predetermine the genetic health, 
gender and coat color of embryos could add value for the potential 
import/export of equine embryos. Increasing the value of embryo 
cryopreservation would open the door to further research in superovulation 






Table 1.  System used to grade the quality of equine embryos* 




Excellent or good: Symmetrical and spherical embryo 
mass with cells of uniform size, color, and density. 
Embryo mass has clear edges without indentation. No 
evidence of cellular fragmentation or loose 
cytoplasmic granules in the perivitelline space. 
 
Grade 2 Fair: Moderate irregularities in the overall shape of the 
embryo, for example, a minor degree of cytoplasmic 
fragmentation evident as slight convolution of the 
edges of the embryo and small cytoplasmic granules 
in the perivitelline space. 
 
Grade 3 Poor: Major irregularities in the shape of the embryonic 
mass or in the size, color, or density of the constituent 
cells. High degree of cytoplasmic fragmentation with 
extrusion or degeneration of cells of variable size 
reflected by highly lobulated, irregular edges of the 
embryonic mass and a large perivitelline space. 
 
Grade 4 Degenerate or dead: High degree of cytoplasmic 
fragmentation. Embryonic cells of irregular size and 
color. Absence of cellular compaction and failure to 
form a clear embryonic mass. This group includes 
embryos with irregularly sized cells of a low number 
inconsistent with the expected stage of development. 
 
* Tremoleda et al., 2003 
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1 8 8 0.4 8 0.0 
2 2 2 0.1 2 0.0 
3 2 8 0.4 8 4.5 
4 8 2 0.1 2 18.0 
N DF Chi-Sq P-Value   










Figure 1.  Microaspiration biopsy technique.  The embryo is placed on a 
holding pipette (A).  A small hole is created in the zona pellucida with the 
biopsy needle (B).  Gentle suction is applied to aspirate a small amount of 





Figure 2.  Organization of the vitrification solutions and diluent solution in a 
petri dish. Volumes of vitrification solutions 1 & 2 (VS 1; VS 2) can be 
approximate; however, precise amounts are needed of vitrification solution 3 
(VS 3) and the diluent solution (DS) when loading the straw (Carnevale, 
2006). 
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 A.           B.  
C.           D.  
 
Figure 3. Examples of embryos before treatment and their morphological 
assessment.  Morula grade 1(A).  Morula grade 2 (B).  Early blastocyst 
grade 1 (C).  Expanding blastocyst grade 2 (D). 
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A.          B.  
C.           D.  
 
Figure 4.  An example of the expansion and hatching seen during in vitro 
culture.  This embryo was vitrified without biopsy.  The embryo is a very 
early blastocyst with only a small blastocele visible after thawing (A).  By 
day 2, the embryo shows significant re-expansion (B).  A small hole has 
formed in the zona pellucida by day 3 (C).  Almost complete hatching by 
day 5 (D). 
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A.           B.  
C.           D.  
Figure 5.  Embryos that hatched earlier expanded to a much greater size 
before degenerating.  This morula (vitrification without biopsy) showed 
some blastomere contraction upon thawing (A), but quickly re-expanded and 
completely hatched by day 3 in culture (B).  The empty zona pellucida was 
visible right next to the expanded blastocyst (C).  Without the glycoprotein 
capsule, the blastocyst rapidly expanded (D). 
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A.           B.  
C.           D.  
 
Figure 6.  Some of the embryos showed blastocele expansion and thinning of 
the zona pellucida without hatching.  This morula (vitrification without 
biopsy) show a great deal of contraction of the blastomeres upon thawing 
(A).  By day 3 a blastocele had developed with thinning of the zona 
pellucida (B).  On day 4, even greater expansion and zona thinning occurred 
(C), but complete degeneration was seen on day 5 (D). 
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A.           B.  
 
C.           D.  
 
Figure 7.  Embryos without developmental potential showed no expansion 
during in vitro culture.  This embryo (biopsy with vitrification) was a grade 
1 morula but showed considerable degeneration upon thawing and the tear in 
the zona pellucida as a result of the biopsy procedure can be clearly seen(A).  
Even greater degeneration can be seen by day 3 (B), day 4 (C), and day 5 
(D) with no zona thinning or embryo expansion. 
Biopsy tear 
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A.           B.  
C.           D.  
 
Figure 8.  The embryos that underwent both biopsy and vitrification hatched 
through the opening created in the zona pellucida by the biopsy procedure.  
This embryo (biopsy with vitrification) was a grade 1 morula that showed 
some degeneration upon thawing (A).  By day 2, it had expanded to a small 
blastocyst (B).  By day 3, greater expansion and zona pellucida thinning was 
evident (C).  Incomplete hatching could be seen by day 5 (D). 
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A.           B.  
 
Figure 9.  This embryo did not survive the vitrification with biopsy 
procedure.  At thaw, the embryo was degenerated with no evidence of an 
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